Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cost-utility Analysis of Office Hysteroscopic Morcellation/Aspiration Versus Conventional Operating-room Resectoscopy for Intrauterine Pathologies

NCT07908615 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07908615 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
Cost-utility Analysis of Office Hysteroscopic Morcellation/Aspiration Versus Conventional Operating-room Resectoscopy for Intrauterine Pathologies
Lead sponsor
Nantes University Hospital
Phase
Not applicable
Overall status
Not yet recruiting
Start date
November 30, 2026
Completion date
March 31, 2030
Enrollment
474 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

retained products of conception, uterine fibroids, uterine polyps

Arms

As registered; 2 arms.

  • Operating-room hysteroscopy with resectoscope Active comparatorOperating-room hysteroscopy with resectoscope

    Participants undergo operative hysteroscopy using a resectoscope in the operating room, with general or regional anesthesia according to the usual care pathway and clinical decision.

  • Outpatient hysteroscopic morcellation/aspiration ExperimentalOutpatient hysteroscopic morcellation/aspiration

    Participants undergo operative hysteroscopy using a morcellation/aspiration system in a dedicated outpatient consultation room, without an operating-room pathway. Analgesia options may include non-steroidal anti-inflammatory medication, local anesthesia, virtual reality and/or an equimolar mixture of oxygen and nitrous oxide, according to participant preference and clinical circumstances.

Primary endpoints

Registered primary outcome measures; 1 primary.

  • Incremental cost-utility ratio of outpatient hysteroscopic morcellation/aspiration versus operating-room resectoscopy Six months after inclusion

    Cost-utility analysis comparing the two care pathways from a collective perspective. Costs and quality-adjusted life years (QALYs) derived from EQ-5D-5L measurements will be compared between groups. The incremental cost-utility ratio will be expressed as cost per QALY and results will also be presented as incremental net monetary benefit at different willingness-to-pay thresholds.

Lead sponsor's other trials

Nantes University Hospital, most recent start first.

Similar trials

Same condition (Leiomyoma) and phase, most recent start first.